AI Article Synopsis
- Evodiae fructus shows potential anti-glioblastoma multiforme (GBM) effects, but its active components and mechanisms are not fully understood.
- The study used network pharmacology to identify 24 active components and 80 drug targets, analyzing their interactions through various bioinformatics tools.
- Results indicated that core active compounds in evodiae fructus have a strong molecular docking affinity with key proteins related to GBM, suggesting multiple molecular targets and pathways for its therapeutic effects.
Article Abstract
Background: Evodiae fructus has been shown to have anti-glioblastoma multiforme (GBM) effects. However, its anti-GBM active components and mechanism remain unclear. In this study, the active components of evodiae fructus were screened by network pharmacology to explore the possible molecular mechanism of resistance to GBM.
Materials And Methods: The main active ingredients of evodiae fructus were derived from Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP) and Batch-traditional Chinese medicine (TCM). TCMSP and Swiss absorption, distribution, metabolism and elimination (ADME) predict genetic targets for ingredients that meet pharmacological criteria. GBM-related targets were obtained from DisGeNet, GeneCards, Online Mendelian Inheritance in Man (OMIM), Therapeutic Target Database (TTD), and TCGA. A Venn diagram was used to obtain the common targets of evodiae fructus and GBM. Protein-protein interaction (PPI) networks and component-disease target networks were constructed using Cytoscape 3.8.1 software for visualization. GBM gene differential expression was visualized by VolcaNoseR, and potential targets were enriched by Gene Ontology (GO) function and annotated by the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway by SRplot. Molecular docking verification was conducted using AutoDock Vina software.
Results: According to the screening conditions, 24 active components and 80 drug targets were obtained. The PPI network contains 80 proteins. The molecular docking verification showed the molecular docking affinity of the core active compounds in evodiae fructus with CASP3, JUN, EGFR, and AKT1.
Conclusions: This study preliminarily identified the various molecular targets and multiple pathways of evodiae fructus against GBM.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524918 | PMC |
| http://dx.doi.org/10.1097/MD.0000000000030853 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
New quinolone alkaloids from Euodia Fruit, and their pancreatic lipase inhibitory and PPAR-γ ligand-binding activities.
Fitoterapia
January 2025
Tokyo University of Pharmacy and Life Sciences, School of Pharmacy, 1432-1, Horinouchi, Hachioji, Tokyo 192-0392, Japan.
Euodia Fruit is a crude drug used to treat migraine and headaches and is well-known to contain indole alkaloids, which may contribute to the observed pharmacological activities. A methanolic extract of Euodia Fruit exhibited pancreatic lipase inhibitory activity (IC 13.9 mg/mL).
View Article and Find Full Text PDFEvodiamine exerts anti-cancer activity including growth inhibition, cell cycle arrest, and apoptosis induction in human follicular thyroid cancers.
Am J Cancer Res
October 2024
Department of Microbiology and Immunology, College of Medicine, Kaohsiung Medical University Kaohsiung 807, Taiwan.
Thyroid cancer (TC) is one of the most prevalent endocrine malignancy with a steadily increasing incidence globally. Although standard treatments like thyroidectomy and radioiodine therapy effectively manage most cases of differentiated thyroid cancers (DTC), certain recurrent cases or those involving poorly differentiated thyroid cancers (PDTC) demand more specialized interventions. Follicular thyroid cancer (FTC) is the second most common type of DTC, and frequently metastasizes through the bloodstream to distant sites such as bones and lungs which is a leading cause of metastatic and recurrent DTC and significantly affects survival.
View Article and Find Full Text PDFAn evodiamine derivative inhibits osteoclast differentiation and protects against OVX-induced bone loss in mice.
Clin Exp Pharmacol Physiol
December 2024
School of Medicine, Shanghai University, Shanghai, China.
Evodiamine is a biologically active alkaloid extracted from the fruit of the traditional Chinese medicine Evodia rutaecarpa (Juss.) Benth. (Fructus Evodiae, Wuzhuyu).
View Article and Find Full Text PDFHigh-Speed Countercurrent Chromatography Isolation of Active Components from Evodia Rutaecarpa and Affinity Ultrafiltration Screening for Their Acetylcholinesterase Inhibitor Activity.
J Sep Sci
October 2024
Central Laboratory, Changchun Normal University, Changchun, Jilin, China.
Article Synopsis
- Researchers screened and prepared acetylcholinesterase (AChE) inhibitors from the plant Evodia rutaecarpa, focusing on three key alkaloids: dehydroevodiamine, evodiamine, and rutecarpine.
- They improved extraction methods by combining traditional response surface methodology with a genetic algorithm, and utilized high-speed countercurrent chromatography to isolate these active compounds.
- The study confirmed the structures of these compounds through nuclear magnetic resonance spectroscopy and validated their neuroprotective properties against cell damage, setting the stage for future development of AChE inhibitors.
The active ingredient of Evodia rutaecarpa reduces inflammation in knee osteoarthritis rats through blocking calcium influx and NF-κB pathway.
Basic Clin Pharmacol Toxicol
December 2024
National Innovation and Attracting Talents "111" base, Key Laboratory of Biorheological Science and Technology, Ministry of Education, College of Bioengineering, Chongqing University, Chongqing, China.
Chronic inflammation significantly contributes to the progression of osteoarthritis (OA), and an anti-inflammatory small molecule derived from medicinal herbs could be a potential drug candidate for OA. Herein, we investigated the function and mechanism of Evodiamine (EAE), the active ingredient from Evodia rutaecarpa, in chondrocytes and macrophages in vitro and in vivo. The cytotoxicity of EAE was determined using an MTT assay.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!